Emcure Pharma shares decline equity worth ₹574 crore changes hands in block deals

July 4, 2025
Uncategorized

On Thursday, July 4, CNBC-TV18 reported, citing sources that Bain Capital-backed BC Investments IV was looking at selling 2.4% stake in the Emcure Pharma for ₹551 crore.

Emcure Pharma shares decline equity worth ₹574 crore changes hands in block deals

Leave a ReplyCancel Reply

How Reliance Industries could add the next $50 billion in market value

Nuvama Wealth clarifies no undisclosed developments amid share price decline

IndusInd Bank Q1 Update: Net advances decline 4%, deposits slightly lower

Equitas Small Finance Bank Q1 Update: Gross advances up 9%, net slippages rise to 4.35%

Mahindra Lifespaces eyes young professionals with premium 1BHK homes in ₹2,500-crore Pune project